Galderma Investigational Site

Berlin 13507

0 studies enrolling now · 4 studies all time

What they study most

Acne Vulgaris, Atopic Dermatitis, Cutaneous T Cell Lymphoma, Prurigo Nodularis

Studies at this site

• Study to Assess the Efficacy and Safety of Nemolizumab (CD14152) in Participants With Prurigo Nodularis (PN) — Completed
• A Safety, Efficacy and Pharmacokinetics Study of CD11301 for the Treatment of Cutaneous T-Cell Lymphoma (CTCL) — Completed
• CD5789 (Trifarotene) Long Term Safety Study on Acne Vulgaris — Completed
• Dose-ranging Study of Nemolizumab in Atopic Dermatitis — Completed